4//SEC Filing
Farzan Nima 4
Accession 0001209191-20-032991
CIK 0001664710other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 5:19 PM ET
Size
5.5 KB
Accession
0001209191-20-032991
Insider Transaction Report
Form 4
Farzan Nima
Director
Transactions
- Award
Stock Option (right to buy)
2020-05-29+8,500→ 8,500 totalExercise: $28.74Exp: 2030-05-29→ Common Stock (8,500 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on each of June 2, 2020, September 2, 2020, December 2, 2020 and March 2, 2021, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Keros Therapeutics, Inc.
CIK 0001664710
Entity typeother
Related Parties
1- filerCIK 0001808296
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 5:19 PM ET
- Size
- 5.5 KB